Bird & Bird advised Biomemory on its €17 million fundraising round

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol

News & Deals

More News & Deals
News Bird & Bird to expand Iberian offering with launch of Lisbon office

Sep 18 2025

Read More
Deal Bird & Bird advises ECBF on Series A financing round in Vegdog

Sep 16 2025

Read More
Deal Bird & Bird advises the University of Hong Kong on the acquisition of a building in Barcelona for its first educational project in Europe

Sep 16 2025

Read More
News Bird & Bird appoints Chris Case as partner in Australia

Sep 16 2025

Read More
Deal Bird & Bird advises Kingyue International and Evolve Capital on Mandatory Unconditional Cash Offer for Samko Timber

Sep 15 2025

Read More
News Bird & Bird appoints energy expert Jenny Murray as new partner

Sep 15 2025

Read More